Literature DB >> 8291611

Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.

P Koskinen1, K Lemström, C Bruggeman, I Lautenschlager, P Häyry.   

Abstract

Clinical and experimental studies have established the accelerating role of cytomegalovirus (CMV) infection on cardiac allograft arteriosclerosis, ie, chronic rejection. We have investigated the mechanisms behind the interaction between CMV infection and chronic rejection. In the first part of the study, 762 endomyocardial biopsy specimens obtained from 47 heart allograft recipients were analyzed. Of these, 28 patients developed CMV infection during the first postoperative year. In 24 of 28 CMV patients, mononuclear inflammatory cells (endothelialitis) were seen in the subendothelium of small intramyocardial arterioles. In CMV-free recipients, only five of 19 had any subendothelial inflammation in the vascular structures P < 0.0001 when compared with CMV patients). The subendothelial inflammation demonstrated an intensive peak at the onset of CMV infection, subsiding slowly thereafter. Morphologically, the inflammatory cells in the subendothelium were small lymphocytes. Only few activated pyroninophilic lymphocytes were seen. Immunohistochemistry revealed that the lymphocytes were mostly T cells (UCHL1+). In the second part of the study, we investigated if a similar endothelialitis could be induced experimentally in allografted rats. We performed rat aortic allografts from the DA (AG-B4, RT1a) donors to the WF (AG-B2, RT1v) recipients and infected the recipients with 10(5) plaque-forming units of rat CMV Maastricht strain 1 day after transplantation. In rat CMV-infected aortic allografts, the frequency of subendothelial leukocyte common antigen (LCA, OX1) positive leukocytes, 1.7 +/- 0.1 (SEM) point score units, was significantly higher when compared to noninfected allografts, 0.8 +/- 0.1 point score units (P < 0.05), and they were most prominent in the intimal space during and following acute infection. During subsequent weeks, the LCA-positive leukocytes were replaced by alpha-actin-positive smooth muscle cells. Instead, most of the cells in intima of CMV-free grafted rats stained positively to alpha-actin from the beginning and were smooth muscle cells. Practically no leukocytes were seen. In rat CMV-infected aortic allografts most subendothelial inflammatory cells represented T cells (W3/25+) and cells of the monocyte/macrophage lineage (OX42+). In conclusion, acute CMV infection is associated with an subendothelial inflammation (endothelialitis) of allograft vascular structures both in human and in rat. Nonactivated T lymphocytes and monocytes predominate the inflammatory lesion in the subendothelium. The results suggest that the virus-linked vascular wall inflammation may play a role in the immune injury toward allograft vascular structures, particularly to endothelium, and thus contribute to allograft arteriosclerosis.

Entities:  

Mesh:

Year:  1994        PMID: 8291611      PMCID: PMC1887122     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens.

Authors:  S Beck; B G Barrell
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

2.  Replication of cytomegalovirus in human arterial smooth muscle cells.

Authors:  J J Tumilowicz; M E Gawlik; B B Powell; J J Trentin
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  CMV infection, class II antigen expression, and human kidney allograft rejection.

Authors:  E von Willebrand; E Pettersson; J Ahonen; P Häyry
Journal:  Transplantation       Date:  1986-10       Impact factor: 4.939

4.  Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression.

Authors:  R S Fujinami; J A Nelson; L Walker; M B Oldstone
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Plaque assay of cytomegalovirus strains of human origin.

Authors:  B B Wentworth; L French
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

6.  Cardiac transplant atherosclerosis.

Authors:  M E Billingham
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

7.  Cytomegalovirus infection of rat endothelial cells in vitro.

Authors:  C A Bruggeman; W M Debie; G Grauls; C P van Boven
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings.

Authors:  S Z Gao; E L Alderman; J S Schroeder; J F Silverman; S A Hunt
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

10.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes.

Authors:  W van der Bij; R Torensma; W J van Son; J Anema; J Schirm; A M Tegzess; T H The
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

View more
  15 in total

Review 1.  The Microbiome, Systemic Immune Function, and Allotransplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 2.  Chronic rejection and late renal allograft dysfunction.

Authors:  J Laine; C Holmberg; P Häyry
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 3.  VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.

Authors:  S Molossi; M Rabinovitch
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.

Authors:  Luciano Potena; Cecile T J Holweg; Marcy L Vana; Leena Bashyam; Jaya Rajamani; A Louise McCormick; John P Cooke; Hannah A Valantine; Edward S Mocarski
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

5.  Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction.

Authors:  Sergio A Torres; Omar Cheema; Dipan J Shah; Guillermo Torre-Amione; Jerry D Estep
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

6.  Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region I.

Authors:  A Legrand; E P Mayer; S S Dalvi; M Nachtigal
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

7.  IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin.

Authors:  Sara Botto; Daniel N Streblow; Victor DeFilippis; Laura White; Craig N Kreklywich; Patricia P Smith; Patrizia Caposio
Journal:  Blood       Date:  2010-10-07       Impact factor: 22.113

8.  Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways.

Authors:  Y H Shen; B Utama; J Wang; M Raveendran; D Senthil; W J Waldman; J D Belcher; G Vercellotti; D Martin; B M Mitchelle; X L Wang
Journal:  Circ Res       Date:  2004-04-22       Impact factor: 17.367

9.  Acute cytomegalovirus infection and transient carotid intimal-medial thickening in a young, otherwise healthy woman.

Authors:  Yasuhiko Hirabayashi; Tomonori Ishii; Takao Kodera; Hiroshi Fujii; Yasuhiko Munakata; Takeshi Sasaki
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 10.  Infection and food combine to cause atherosclerotic coronary heart disease - Review and hypothesis.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.